Enanta Pharmaceutica (ENTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 34,438 | 39,480 | -10,573 | -5,370 | 9,627 |
| Depreciation Amortization | 2,472 | 1,878 | 1,356 | 710 | 1,483 |
| Income taxes - deferred | -15,211 | -15,228 | N/A | N/A | N/A |
| Accounts receivable | -916 | 409 | -190 | 529 | 241 |
| Accounts payable and accrued liabilities | 399 | -190 | 316 | -648 | 115 |
| Other Working Capital | -2,258 | -1,259 | -1,634 | -1,167 | 741 |
| Other Operating Activity | 1,255 | 21 | 724 | 75 | -1,554 |
| Operating Cash Flow | $20,179 | $25,111 | $-10,001 | $-5,871 | $10,653 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,028 | -543 | -165 | -24 | -606 |
| Purchase Of Investment | -98,405 | -85,750 | -24,572 | -10,221 | -115,888 |
| Sale Of Investment | 99,927 | 77,577 | 43,334 | 11,594 | 47,278 |
| Other Investing Activity | 3 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $497 | $-8,716 | $18,597 | $1,349 | $-69,216 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 1,054 | 1,015 | 646 | 89 | 60,451 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -3,540 |
| Other Financing Activity | 110 | 105 | 0 | 0 | 0 |
| Financing Cash Flow | $1,164 | $1,120 | $646 | $89 | $56,911 |
| Beginning Cash Position | 8,859 | 8,859 | 8,859 | 8,859 | 10,511 |
| End Cash Position | 30,699 | 26,374 | 18,101 | 4,426 | 8,859 |
| Net Cash Flow | $21,840 | $17,515 | $9,242 | $-4,433 | $-1,652 |
| Free Cash Flow | |||||
| Operating Cash Flow | 20,179 | 25,111 | -10,001 | -5,871 | 10,653 |
| Capital Expenditure | -1,028 | -543 | -165 | -24 | -606 |
| Free Cash Flow | 19,151 | 24,568 | -10,166 | -5,895 | 10,047 |